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Growth/differentiation factor-10 (GDF-10) is a TGF-b family member highly related to bone morphogenetic protein-3. In
order to determine the biological function of GDF-10, we carried out a detailed analysis of the expression pattern of GDF-10
and characterized GDF-10-null mice that we generated by gene targeting. During embryogenesis GDF-10 is expressed
prominently in developing skeletal structures both in the craniofacial region and in the vertebral column. In adult animals,
GDF-10 is expressed at high levels in the brain, where GDF-10 is localized primarily to cells in the Purkinje cell layer of the
cerebellum, and in the uterus, where the expression levels of GDF-10 are regulated both during the menstrual cycle and
during pregnancy. Despite the high levels of GDF-10 expression in these tissues, we found no obvious abnormalities in
GDF-10-knockout mice with respect to the development of these tissues. These findings suggest either that GDF-10 plays
no regulatory role in these tissues or that its function is redundant with that of other growth factor-like
molecules. © 1999 Academic Press
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one morphogenetic protein 3 (BMP-3).INTRODUCTION
Members of the transforming growth factor-b (TGF-b)
superfamily play central roles in regulating cell growth and
differentiation during development and in adult tissues (for
review see McPherron and Lee, 1996). To date, over 30
mammalian members of the TGF-b superfamily have been
escribed. These include the TGF-bs (Derynck et al., 1985),
bone morphogenetic proteins (BMPs) (Kingsley et al., 1992;
Storm et al., 1994; Wozney et al., 1988), Mu¨llerian inhibit-
ng substance (Behringer et al., 1990; Cate et al., 1986),
activins and inhibins (Forage et al., 1986; Mason et al.,
1985; Mayo et al., 1986), nodal (Zhou et al., 1993), lefty
Meno et al., 1996, 1998), TGF-b-related neurotrophic fac-
ors (GDNF (Lin et al., 1993), neurturin (Horger et al., 1998;
Kotzbauer et al., 1996), and persephin (Milbrandt et al.,
1998)), and a large, heterogeneous group of proteins termed
growth/differentiation factors (GDFs) (Lee, 1991; McGrath
et al., 1995; McPherron et al., 1997; McPherron and Lee,
1993).
The primary structures of all TGF-b family members1 To whom correspondence should be addressed.
68share several common features. Each family member is
synthesized as a precursor protein with a signal sequence,
an amino-terminal pro- region, and a conserved carboxy-
terminal domain. The biologically active molecule is be-
lieved to be a dimer of C-terminal domains generated by
proteolytic cleavage of the precursor protein. The mature
carboxy-terminal regions of all family members share some
degree of homology at the primary amino acid sequence
level and contain six to nine cysteine residues with a
characteristic spacing. For several family members for
which the three-dimensional structure has been deter-
mined (Daopin et al., 1992; Griffith et al., 1996; Mittl et al.,
1996; Schlunegger and Grutter, 1992), it is known that six
cysteine residues form three intramolecular disulfide bonds
that are arranged in a characteristic cystine knot configura-
tion. Although the C-terminal sequences of all family
members are somewhat related, these proteins can be
divided into subgroups of highly related factors. Within a
given subgroup, factors generally show 70–90% amino acid
sequence identity, whereas between subgroups, the homol-
ogy generally falls in the range of 20–50% identity.Growth/differentiation factor-10 (GDF-10) is a new
TGF-b family member of unknown function. GDF-10 was
0012-1606/99 $30.00
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69Characterization of GDF-10originally identified by PCR using degenerate oligonucleo-
tides based on the BMP-3 sequence (Cunningham et al.,
1995). Among the known mammalian family members,
GDF-10 is most highly related to BMP-3. GDF-10 and
BMP-3 show 83% amino acid sequence identity in the
C-terminal region and form their own subgroup within the
TGF-b superfamily. Among a variety of adult tissues
screened by Northern analysis, GDF-10 was shown to be
expressed at highest levels in uterus, adipose tissue, and
brain and at lower levels in liver and spleen. GDF-10
mRNA was also detected in calvarial bone in both neonatal
and adult animals. Here we report a detailed characteriza-
tion of the expression pattern of GDF-10 and an analysis of
GDF-10-null mice that we generated by gene targeting. We
find that despite the high levels of GDF-10 expression in
discrete cell populations during development and in adult
tissues, GDF-10 appears to be dispensable for proper devel-
opment of these cell types.
MATERIALS AND METHODS
Probes and in Situ Hybridization
The amino-terminal coding sequence of GDF-10 was used as a
probe for all in situ hybridization experiments in order to avoid
possible cross-hybridization with related family members. Brains
and embryos were fixed in 4% paraformaldehyde, embedded in
paraffin, and sectioned (8 mm) using a microtome. Uteri from
nonpregnant and 5.5-day-pregnant female mice were frozen in
liquid nitrogen and sectioned (10 mm) at 220°C using a cryostat.
Riboprobes were prepared with either [35S]- or [33P]UTP using a
tratagene in vitro transcription kit. In situ hybridization was
arried out as described (Andreasson and Worley, 1995; Wilkinson
t al., 1987). Hybridized sections were exposed to photographic
mulsion, developed, and stained with hematoxylin and eosin or
oluidine blue.
Northern Analysis
Northern analysis was carried out with 20 mg of total RNA (brain
samples) or 2 mg of twice-poly(A)-selected RNA (uterine samples) as
described previously (Lee, 1990). All uterine RNAs were pooled
from four mice except for 18.5-day and labor, which represent a
single animal sample. The blots were stripped and hybridized to a
tubulin probe as a control for loading.
RNase Protection Assay
Total RNAs were isolated using RNAzol from the uterus of
individual female mice. A 320-bp fragment corresponding to the
C-terminal region of GDF-10 and a 250-bp fragment from the actin
gene were used as probes. The GDF-10 and actin probes were
labeled with [32P]UTP and [33P]UTP, respectively, in order to
ompensate for differences in the abundance of each RNA. Probes
ere purified on a 5% acrylamide gel with 8 M urea. Five
icrograms of total RNA was mixed with 105 cpm of each probe
nd processed using an Ambion RPA kit. Digested probes were
eparated on a 5% acrylamide gel with 8 M urea. Quantification of
ignals was carried out using a phosphorimager.
s
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The structure of the GDF-10 gene was determined by restriction
mapping and partial sequence analysis of phage clones isolated
from a 129 Sv/J genomic library. The targeting construct was
transfected into R1 embryonic stem cells (kindly provided by A.
Nagy, R. Nagy, and W. Abramow-Newerly). Following selection
with gancyclovir (2 mM) and G418 (250 mg/ml), targeted clones
identified by Southern analysis were injected into C57BL/6 blasto-
cysts and transferred into pseudopregnant females.
Immunohistochemistry of Cerebellar Sections
Eight-micrometer paraffin cerebellar sections from wild-type,
heterozygous, and homozygous mice at 1 week, 2 weeks, 4 months,
and 10 months of age were incubated with either monoclonal
anti-calbindin (Sigma) or polyclonal anti-GFAP (DAKO) antibodies
at a 1:200 or 1:2000 dilution, respectively. Immunohistochemistry
was carried out as described (Cartun and Pedersen, 1989). Sections
were counterstained with hematoxylin. For quantification of Pur-
kinje cell densities, five to eight sections were measured for each
mouse at10 months of age, and the results from three to five mice
for each genotype were combined.
Rotating Wheel Test
GDF-10-homozygous mutant mice and wild-type littermates
were tested at the ages of 5 weeks or 2 months. Mice were placed
on a stationary wheel, and then the wheel was rotated at 7 rpm.
The amount of time that the mouse remained on the wheel was
recorded. All the mice were given five trials of practice with 2
min in between, and the results of the sixth trial are contained
in Table 1.
RESULTS
By Northern analysis, GDF-10 was previously shown to
be expressed in a wide range of adult tissues, including the
brain, uterus, fat, and bone (Cunningham et al., 1995). To
begin to understand the biological functions of GDF-10 in
these and other tissues, we carried out a detailed analysis of
the expression pattern of GDF-10 in both adult and embry-
onic tissues.
Expression of GDF-10 during Embryogenesis
To determine whether GDF-10 is expressed during em-
bryogenesis, Northern analysis was carried out using
poly(A)-selected RNAs prepared from whole mouse em-
bryos and placentas at various developmental stages. As
shown in Fig. 1A, GDF-10 mRNA was detected in embryos
at all stages examined from day 8.5 to day 18.5 pc with the
highest levels of expression being detected at day 12.5 pc. In
contrast, GDF-10 mRNA was not detected in the placenta
at any stage examined (Fig. 1B).
In order to localize sites of GDF-10 expression during
embryogenesis, we carried out in situ hybridization to
agittal sections of day 12.5 and day 14.5 pc embryos. For
hese and all subsequent in situ hybridization experiments,
s of reproduction in any form reserved.
w
i
l
N
R
D
E
P
G
L
e
s
70 Zhao, Lawler, and Leea probe corresponding to the amino-terminal coding region
of GDF-10 was used to avoid possible cross-hybridization to
related family members, such as BMP-3, whose amino acid
sequence in the mature C-terminal region is 83% identical
to that of GDF-10. At both day 12.5 and day 14.5 pc,
GDF-10 mRNA was primarily localized to developing skel-
etal structures. The expression of GDF-10 in developing
bone was most striking in the axial skeleton, where GDF-10
mRNA was detected in alternating condensations through-
out the vertebral column (Figs. 2A, 2B, and 2E). The
expression of GDF-10 in developing bone was also observed
in the craniofacial region in the developing cartilage of the
palate (Fig. 2B), nasal cavity (Fig. 2D), and calvarium in the
occipital region (Fig. 2F). Prominent expression of GDF-10
TABLE 1
Analysis of GDF-10-Null Mice
Genotype 1/1
umber of Purkinje cells/mm
(10 months) 34.1 6 8.1 (n 5 24)
otating rod test (s)
5 weeks 53.0 6 8.1 (n 5 4)
2 months 59.5 6 1.0 (n 5 8)
istance between steps (cm)
(2 months) 2.8 6 0.4 (n 5 4)
strous cycle (days) 5.5 6 1.2 (n 5 16)
regnancy rate (%) 60.0 (n 5 5)
estation length (days) ND
itter size ND
FIG. 1. Northern analysis of GDF-10 expression in developing
mbryos (A) and placentas (B). Two micrograms of twice-poly(A)-
elected mRNA was loaded in each lane.
Copyright © 1999 by Academic Press. All rightas also seen in the developing inner ear (Fig. 2C) as well as
n some soft tissues, such as the upper lip (Fig. 2D) and
ower jaw (data not shown).
Expression of GDF-10 in the Brain
GDF-10 was previously shown to be expressed in adult
brain (Cunningham et al., 1995). In order to identify the
regions of the brain in which GDF-10 is expressed, we
carried out in situ hybridization analysis of sections pre-
pared from whole mouse brains. From preliminary experi-
ments, we determined that the cerebellum was the pre-
dominant site of GDF-10 expression (data not shown). We
also confirmed this finding by Northern analysis; as shown
in Fig. 3, GDF-10 mRNA was present at high levels in
cerebellum and in whole brain but at very low levels in
brains from which the cerebellum had been removed.
Therefore, in all subsequent in situ localization experi-
ments, we restricted our analysis to the cerebellum.
As shown in Fig. 4A, GDF-10 mRNA was localized exclu-
sively to the Purkinje cell layer of the cerebellum. At higher
magnification, it was clear that the hybridization signal was
restricted to small cells surrounding the Purkinje cells but not
to the Purkinje cells themselves (Fig. 4B). To better define
these cells expressing GDF-10, we analyzed the pattern of
GDF-10 expression at various stages of cerebellar develop-
ment beginning with newborn mice, in which migration of
granule cells had not yet been initiated. As shown in Figs. 4C
and 4D, the expression of GDF-10 in newborn mice was
detected in a diffuse band of cells below the external granule
cell layer. During the first 2 weeks of postnatal development,
the expression of GDF-10 mRNA became more intense and
focused in the Purkinje cell layer, so that by postnatal day 14,
the expression pattern of GDF-10 in the cerebellum closely
resembled that of adult animals (Figs. 4E–4L).
The fact that the GDF-10-expressing cells remained in
the vicinity of Purkinje cells throughout cerebellar devel-
1/2 2/2
31.4 6 6.2 (n 5 35) 37.5 6 6.6 (n 5 38)
59.0 6 3.5 (n 5 12) 52.3 6 14.7 (n 5 10)
60.0 6 0.0 (n 5 14) 58.7 6 2.3 (n 5 12)
2.8 6 0.5 (n 5 9) 2.9 6 0.5 (n 5 8)
5.6 6 0.8 (n 5 15) 5.4 6 1.0 (n 5 16)
58.6 (n 5 29) 60.0 (n 5 25)
18.5 6 0.5 (n 5 17) 18.8 6 0.6 (n 5 15)
7.3 6 3.2 (n 5 17) 7.4 6 2.9 (n 5 15)opment rather than undergoing migration as is characteris-
tic of granule cells suggested that these cells were not of
s of reproduction in any form reserved.
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71Characterization of GDF-10granule cell origin. In order to determine whether the
GDF-10-expressing cells represented Bergmann glia, we
compared the GDF-10 expression pattern to that obtained
by immunohistochemistry using an anti-GFAP antibody,
which labels Bergmann glial cells and astrocytes in cerebel-
lum (Schachner et al., 1977). In the cerebellum, the GFAP
ntibody detected cell bodies and processes in both the
olecular layer and the granule cell layer, but the overall
attern of staining did not appear to overlap with that seen
y in situ hybridization using a GDF-10 probe (Fig. 5).
Hence, the GDF-10-expressing cells are unlikely to corre-
spond to Bergmann glia.
Expression of GDF-10 in the Uterus
FIG. 2. GDF-10 expression in embryos by in situ hybridization
hybridized to a GDF-10 antisense probe. (A) Low magnification of
GDF-10 expression in the palate (arrow) and cervical vertebra (ar
(arrowhead) (D), tail region (arrow) (E), and occipital bone (arrow) (By Northern analysis, GDF-10 was also shown to be
expressed in the uterus of adult mice. In order to understand
G
n
Copyright © 1999 by Academic Press. All righthe role that GDF-10 plays in this tissue, we examined the
xpression pattern of GDF-10 in the uterus both during
regnancy and during the normal menstrual cycle. As
hown in Fig, 6A, the expression levels of GDF-10 were
egulated during pregnancy. GDF-10 mRNA appeared to
ncrease immediately after conception, reach peak levels
uring the first week of pregnancy, and then gradually
ecrease to barely detectable levels by the end of the
estational period. Immediately following delivery, GDF-10
evels increased dramatically. By in situ hybridization anal-
sis of a day 5.5 pregnant uterus, GDF-10 expression was
bserved in the proliferating stromal cells between implan-
ation sites but not in the decidualized cells (Fig. 6B).
We also examined the uterine expression pattern of
DF-10 in nonpregnant animals. By in situ hybridization,
tions from 12.5- (A, B, C) and 14.5-day (D, E, F) embryos were
10 expression in a 12.5-day embryo. (B–F) Higher magnification of
ead) (B), inner ear (arrow) (C), upper lip (arrow) and nasal cavity. Sec
GDF-DF-10 appeared to be expressed in the stromal cells but
ot in the epithelial cells in normal cycling females (Fig.
s of reproduction in any form reserved.
72 Zhao, Lawler, and Lee6C). To determine whether the levels of GDF-10 changed
during the menstrual cycle, we carried out RNase protec-
tion analysis of RNAs prepared from females in which the
stage of the menstrual cycle had been assessed by vaginal
smears. As shown in Fig. 6E, GDF-10 mRNA was present at
relatively high levels during diestrus and early proestrus,
when the uterine endometrium is quiescent, and at rela-
tively low levels during estrus and metestrus, when the
uterine endometrium is undergoing active proliferation and
degeneration.
Generation and Characterization of GDF-10-Null
Mice
In order to determine the biological function of GDF-10
in mice, we generated mice in which most of the GDF-10
coding region had been deleted by gene targeting. GDF-10
was originally mapped to the proximal region of mouse
chromosome 14 (Cunningham et al., 1995). We isolated
three overlapping genomic clones from a 129 Sv/J genomic
library using a GDF-10 probe and determined the structure
of the GDF-10 gene using a combination of restriction
mapping, Southern analysis, and partial DNA sequencing.
As shown in Fig. 7A, the GDF-10 gene consists of three
exons spreading over approximately 12 kb. The mature
C-terminal region of the GDF-10 protein is encoded in
portions of exon 2 and exon 3. In order to ensure that the
resulting mice would be null for GDF-10 function, we
generated a targeting construct in which the entire second
and third exons were replaced with a neo cassette (Fig. 7A).
The targeting construct was electroporated into R1 em-
bryonic stem (ES) cells, and G418/ganciclovir doubly resis-
FIG. 3. GDF-10 expression in the brain and cerebellum. Total
RNAs (20 mg) prepared from whole brains of adult CD-1 mice,
brains from which the cerebellum had been removed (brain 2
cerebellum), or cerebellum (two independent samples) were elec-
trophoresed, blotted, and probed with either GDF-10 or a tubulin
control.tant clones were screened by Southern analysis using a 1-kb
probe from outside the targeting construct (Fig. 7A). From a
Copyright © 1999 by Academic Press. All righttotal of 297 ES cell clones analyzed in this manner, we
identified 8 in which the targeting construct had recom-
bined at the GDF-10 locus. Following blastocyst injection
of these clones, we obtained one male chimera that trans-
mitted the mutant allele through the germ line. Homozy-
gous mutant mice were obtained from crosses of F1 het-
erozygotes. In order to confirm that homozygous mice were
truly null for GDF-10, we carried out Northern analysis of
RNA prepared from the cerebellum of wild-type, heterozy-
gous, and homozygous mice. As shown in Fig. 7B, GDF-10
mRNA was undetectable in the cerebellum of homozygous
mutants. Genotypic analysis (Fig. 7C) of 165 offspring
derived from matings of heterozygous mice showed that
wild-type, heterozygous, and homozygous GDF-10 mutants
were obtained at a ratio close to 1:2:1 (40:77:48). Homozy-
gous mutants were viable and appeared grossly normal.
Preliminary histopathological examination of many of the
major organs also revealed no obvious abnormalities (data
not shown).
Based on the expression pattern of GDF-10 during devel-
opment and in adult mice, we focused our analysis on those
tissues in which the expression of GDF-10 was shown to be
the highest. As discussed above, GDF-10 is expressed in
developing skeletal structures. In order to determine
whether skeletal development was affected by the GDF-10
mutation, we prepared skeletons of wild-type and mutant
embryos and mice that had been stained with Alizarin red
and Alcian blue. Among 31 homozygous mutants exam-
ined, no obvious abnormalities were observed in either the
craniofacial region or the axial skeleton (data not shown).
We also carried out a detailed analysis of the cerebellum
of homozygous mutants. In order to assess whether cerebel-
lar development was abnormal, we prepared cerebellar
sections from wild-type and mutant mice at 1 week, 2
weeks, and 4 months of age. In addition, we examined the
cerebellum from 10-month-old animals to look for signs of
neuronal degeneration in the mutants. By histological ex-
amination, the cerebellum from GDF-10 mutant animals
appeared grossly normal and showed the typical organiza-
tion of the three major cell layers (Fig. 8). We also performed
immunohistochemistry studies using anti-calbindin anti-
bodies to assess Purkinje cell development. At all stages
examined, the distribution and number of Purkinje cells in
the mutants were indistinguishable from those in wild-type
mice (Figs. 8A–8C, 8E, and 8F; Table 1). Hence, the devel-
opment of Purkinje cells appeared to be grossly normal in
the mutants, and there appeared to be no significant loss of
Purkinje cells as the animals aged. Similarly, immunohis-
tochemical analysis using anti-GFAP antibodies revealed
no obvious differences in glial cells between wild-type and
mutant animals (Fig. 8D).
In order to test cerebellar function in the mutants, we
carried out two tests to assess balance and motor control.
First, we examined their gaits. The gaits of mutant mice
appeared normal, and measurement of the distance between
steps revealed no differences between wild-type and mutant
animals (Table 1). Second, we subjected the mice to the
s of reproduction in any form reserved.
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73Characterization of GDF-10FIG. 4. GDF-10 expression in cerebellum by in situ hybridization. Cerebellar sections prepared from adult (A, B), newborn (C, D),
.5-day-old (E, F), 6.5-day-old (G, H), 10.5-day-old (I, J), and 14.5-day-old (K, L) mice were hybridized to a GDF-10 antisense probe.
epresentative Purkinje cells are marked by arrowheads. PCL, Purkinje cell layer; GL, granule cell layer; ML, molecular layer; EGL, external
ranule cell layer.
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74 Zhao, Lawler, and Leerotating rod test. As shown in Table 1, the ability of mutant
animals to remain on the rotating rod was comparable to
that of wild-type and heterozygous mice.
Finally, because GDF-10 is expressed at high levels in the
uterus, we examined the reproductive function of mutant
FIG. 5. Comparison of GDF-10 expression in the cerebellum with
markers for different cell types. (A) In situ hybridization showing
DF-10 expression in cells surrounding Purkinje cells. (B) Dark-
eld view of A. (C) Anti-GFAP antibody staining of adult cerebel-
um sections, showing staining of glial cells and their processes in
he molecular layer and granule cell layer. (D) Anti-calbindin
taining of cerebellum sections showing Purkinje cells (red) in a
ingle layer.
FIG. 6. GDF-10 expression in uterus. (A) Analysis of GDF-10 e
normalized to tubulin (d, days of gestation; dp, days after birth). (B)
C, conceptus). (C) In situ hybridization analysis of GDF-10 expres
tain of a section next to the one shown in C. (E) Analysis of GDF-10 e
DF-10 expression levels were normalized to an actin control.
Copyright © 1999 by Academic Press. All rightemales. An analysis of the estrous cycle determined by
aily serial vaginal smears over a period of 12 days showed
o differences between wild type and homozygous mutants
ith respect to the average length of the cycle (Table 1). The
ertility of GDF-10 homozygous mutants was also compa-
able to that of wild-type mice by a variety of criteria. As
hown in Table 1, the frequency with which the animals
ecame pregnant (relative to the frequency of vaginal plugs),
he gestational length, and the litter size were all similar
etween wild-type and homozygous mutant mice.
DISCUSSION
GDF-10 was originally identified in a screen for novel
TGF-b family members using a degenerate PCR strategy
(Cunningham et al., 1995). Among the known TGF-b fam-
ily members, GDF-10 is most highly related to BMP-3.
GDF-10 and BMP-3 are 83% identical in the mature
C-terminal region and form their own distinct subgroup
within the TGF-b superfamily. GDF-10 was previously
shown to be expressed at high levels in several adult tissues,
but the biological function of GDF-10 is unknown. In this
report, we have provided a detailed analysis of the expres-
sion pattern of GDF-10 in both embryonic and adult tissues
and a characterization of GDF-10-null mice that we gener-
ated by gene targeting.
We have shown that during embryonic development,
GDF-10 is expressed most prominently in developing skel-
etal structures. In this respect, a number of known TGF-b
family members have been shown to play important roles
in regulating skeletal development. In fact, the bone mor-
phogenetic proteins were originally identified for their
ability to induce de novo endochondral bone formation
when implanted subcutaneously or intramuscularly into
rodents (Wozney et al., 1988), and several TGF-b family
members have been shown to be essential for proper skel-
etal development in mice. For example, mutations in
BMP-5 result in a variety of skeletal defects affecting the
external ears, sternum, ribs, and vertebrae (King et al.,
1994), and mutations in GDF-5 lead to defects in the
development of long bones and digits (Storm et al., 1994).
he expression pattern of GDF-10 and the high degree of
omology between GDF-10 and BMP-3 suggest that
DF-10 may also be involved in regulating cartilage and/or
one development.
We have also examined the expression pattern of GDF-10
n adult tissues. In the brain, GDF-10 is expressed at highest
evels in the cerebellum, where the expression of GDF-10 is
sion levels in the uterus during pregnancy. GDF-10 levels were
tu hybridization analysis of GDF-10 expression in pregnant uterus
in normal uterus (S, stromal cells; E, epithelial cells). (D) An H&Expres
In si
sionxpression levels in the uterus during the normal menstrual cycle.
s of reproduction in any form reserved.
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76 Zhao, Lawler, and Leehighly localized to small cells in the Purkinje cell layer.
Based on an analysis of GDF-10 expression during cerebellar
development as well as immunohistochemical studies, it
appears that the GDF-10-expressing cells are not Purkinje
cells, granule cells, or Bergmann glial cells. The distribution
of the GDF-10-expressing cells also does not correspond to
the known distribution of either basket cells or stellate
cells (Altman, 1972). One other cerebellar cell type, the
Lugaro cell, has been reported to reside in the Purkinje cell
layer (Sahin and Hockfield, 1990). However, the ratio of
Lugaro cells to Purkinje cells has been reported to be
approximately 1:20, and our experiments indicate that the
GDF-10-expressing cells appear to be more abundant than
Purkinje cells. Hence, the GDF-10-expressing cells are
unlikely to represent Lugaro cells and most likely represent
a subpopulation of cells for which specific morphologic
FIG. 7. Construction and analysis of GDF-10-null mice. (A) Map
line). (h) Exons of GDF-10, (n) C-terminal region of GDF-10 coding
(B) Northern analysis of GDF-10 expression in the cerebellum of
analysis of knockout mice. Mice 1 and 3 are F1 heterozygous mice
3. Genomic DNAs were digested with BamHI, and expected fragmcharacteristics or molecular makers have not yet been
identified.
t
r
Copyright © 1999 by Academic Press. All rightThe expression pattern of GDF-10 in the cerebellum
uggests that GDF-10 plays a role in regulating cerebellar
evelopment or function, perhaps of the Purkinje cells
hemselves. Indeed, other members of the TGF-b family,
ncluding several BMPs, activin, TGF-b, GDF-7, GDNF,
eurturin, and persephin, have been shown to be important
egulators of neuronal survival and differentiation. In fact,
DNF has been shown to be capable of promoting the
urvival and differentiation of Purkinje cells in dissociated
ultures of embryonic rat cerebellum (Mount et al., 1995)
nd rescuing loss of Purkinje cells induced by ethanol in
xplant cultures of developing cerebellum (McAlhany et al.,
997). It will be important to determine whether GDF-10
as a similar biological activity in vitro.
In the uterus, GDF-10 was found to be expressed in the
tromal cells but not in the epithelial cells. We also showed
GDF-10 genomic locus (top line) and targeting construct (bottom
ence. K, KpnI; X, XbaI; B, BamHI; H, HindIII; R, EcoRI; RV, EcoRV.
-type, heterozygous, and homozygous mutant mice. (C) Southern
mice 18–27 are F2 offspring derived from a mating of mice 1 and
for wild-type and targeted alleles were 21 and 19 kb, respectively.of the
sequ
wildhat the expression levels of GDF-10 in the uterus are
egulated both during pregnancy and during the normal
s of reproduction in any form reserved.
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77Characterization of GDF-10menstrual cycle. During pregnancy, the expression levels of
GDF-10 were highest during the early stages and gradually
decreased until birth. During the menstrual cycle, the
expression levels of GDF-10 were highest during diestrus
and early proestrus. While an autocrine or paracrine role for
GDF-10 in regulating either stromal cell or epithelial cell
growth seems most likely, an elucidation of specific bio-
logical function of GDF-10 in the uterus will require an
analysis of the effects of GDF-10 in vitro and a determina-
tion of the distribution of GDF-10 receptors.
Whatever biological functions GDF-10 may carry out
in these and other tissues, the GDF-10-knockout mice
appear to be relatively normal in terms of the develop-
ment of the tissues in which GDF-10 is expressed at
FIG. 8. Immunohistochemical analysis of cerebellar sections from
4 months (C, D), and 10 months (E, F) of age. Anti-calbindin antibod
anti-GFAP antibodies were used.highest levels. In particular, to the extent that we have
examined, the development of the skeleton and cerebel-
t
o
Copyright © 1999 by Academic Press. All rightum as well as female reproductive function all appear to
e indistinguishable between wild-type and GDF-10 mu-
ant animals. It is certainly possible that the GDF-10
utant animals have some subtle defects that were not
ncovered in our analysis or that these mutants have
henotypes that are not apparent under standard labora-
ory conditions. Alternatively, it is possible that the loss
f GDF-10 function is compensated by other growth
actor-like molecules in the mutant mice. In this regard,
likely candidate for a molecule that may have biological
ctivities similar to those of GDF-10 is BMP-3. In vivo,
MP-3 has been shown to be expressed in a wide range of
issues (Takahashi and Ikeda, 1996), including some in
hich GDF-10 is expressed. Clearly, an understanding of
F-10-knockout and -heterozygous mice at 1 week (A), 2 weeks (B),
ere used for all experiments except for those shown in D, in whichGDhe biological function of GDF-10 will await an analysis
f the phenotype of mice lacking both GDF-10 and BMP-3
s of reproduction in any form reserved.
AD
D
K
L
L
M
M
78 Zhao, Lawler, and Leeas well as an analysis of the biological effects of GDF-10
protein on cultured cells.
ACKNOWLEDGMENTS
We thank Paul Dunlap for assistance in maintaining mice. This
work was supported by a grant from the NIH (to S.-J.L). The factor
described in this article was licensed by the Johns Hopkins Uni-
versity to MetaMorphix, Inc., and sublicensed to American Home
Products. S.-J.L is entitled to a share of royalty received by the
University from sales of this factor and is a consultant to Meta-
Morphix, Inc. S.-J.L. and the University own MetaMorphix stock,
which is subject to certain restrictions under University policy.
The terms of these arrangements are being managed by the Uni-
versity in accordance with its conflict of interest policies.
REFERENCES
Altman, J. (1972). Postnatal development of the cerebellar cortex in
the rat. J. Comp. Neurol. 145, 353–514.
ndreasson, K., and Worley, P. (1995). Induction of beta-A activin
expression by synaptic activity and during neocortical develop-
ment. Neuroscience 69, 781–796.
Behringer, R. R., Cate, R. L., Froelick, G. J., Palmiter, R. D., and
Brinster, R. L. (1990). Abnormal sexual development in trans-
genic mice chronically expressing Mullerian inhibiting sub-
stance. Nature 345, 167–170.
Cartun, R., and Pedersen, C. (1989). An immunocytochemical
technique offering increased sensitivity and lowered cost with a
streptavidin horseradish-peroxidase conjugate. J. Histotechnol.
12, 273–277.
Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M.,
Cheung, A., Ninfa, E. G., Frey, A. Z., Gash, D. J., Chow, E. P.,
Fisher, R. A., Bertonis, J. M., Torres, G., Wallner, B. P., Ra-
machandran, K. L., Ragin, R. C., Manganaro, T. F., MacLaughlin,
D. T., and Donahoe, P. K. (1986). Isolation of the bovine and
human genes for Mullerian inhibiting substance and expression
of the human gene in animal cells. Cell 45, 685–698.
Cunningham, M. S., Jenkins, N. A., Gilbert, D. J., Copeland, N. G.,
Reddi, A. H., and Lee, S.-J. (1995). Growth/differentiation factor-
10: A new member of the transforming growth factor-b super-
family related to bone morphogenetic protein-3. Growth Factors
12, 99–109.
aopin, S., Piez, K. A., Ogawa, Y., and Davies, D. R. (1992). Crystal
structure of transforming growth factor-b2: An unusual fold for
the superfamily. Science 257, 369–373.
erynck, R., Jarrett, J. A., Chen, E. Y., Eaton, D. H., Bell, J. R.,
Assoian, R. K., Roberts, A. B., Sporn, M. B., and Goeddel, D. V.
(1985). Human transforming growth factor-b complementary
DNA sequence and expression in normal and transformed cells.
Nature 316, 701–705.
Forage, R. G., Ring, J. M., Brown, R. W., McInerney, B. V., Cobon,
G. S., Gregson, R. P., Robertson, D. M., Morgan, F. J., Hearn,
M. T. W., Findlay, J. K., Wettenhall, R. E. H., Burger, H. G., and
de Kretser, D. M. (1986). Cloning and sequence analysis of cDNA
species coding for the two subunits of inhibin from bovine
follicular fluid. Proc. Natl. Acad. Sci. USA 83, 3091–3095.
Griffith, D. L., Keck, P. C., Sampath, T. K., Rueger, D. C., and
Carlson, W. D. (1996). Three-dimensional structure of recombi-
nant human osteogenic protein 1: Structural paradigm for the
Copyright © 1999 by Academic Press. All righttransforming growth factor b superfamily. Proc. Natl. Acad. Sci.
USA 93, 878–883.
Horger, B., Nishimura, M., Armanini, M., Wang, L., Poulsen, K.,
Rosenblad, C., Kirik, D., Moffat, B., Simmons, L., Johnson, E. J.,
Milbrandt, J., Rosenthal, A., Bjorklund, A., Vandlen, R., Hynes,
M., and Phillips, H. (1998). Neurturin exerts potent actions on
survival and function of midbrain dopaminergic neurons. J. Neu-
rosci. 18, 4929–4937.
King, J. A., Marker, P. C., Seung, K. J., and Kingsley, D. M. (1994).
BMP5 and the molecular, skeletal, and soft-tissue alterations in
short ear mice. Dev. Biol. 166, 112–122.
Kingsley, D. M., Bland, A. E., Grubber, J. M., Marker, P. C., Russell,
L. B., Copeland, N. G., and Jenkins, N. A. (1992). The mouse
short ear skeletal morphogenesis locus is associated with defects
in a bone morphogenetic member of the TGFb superfamily. Cell
71, 399–410.
otzbauer, P. T., Lampe, P. A., Heuckeroth, R. O., Golden, J. P.,
Creedon, D. J., Johnson, E. M., Jr., and Milbrandt, J. (1996).
Neurturin, a relative of glial-cell-line-derived neurotrophic fac-
tor. Nature 384, 467–470.
Lee, S.-J. (1990). Identification of a novel member of the transform-
ing growth factor-b superfamily. Mol. Endocrinol. 4, 1034–1040.
ee, S.-J. (1991). Expression of growth/differentiation factor 1 in the
nervous system: Conservation of a bicistronic structure. Proc.
Natl. Acad. Sci. USA 88, 4250–4254.
in, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S., and Collins, F.
(1993). GDNF: A glial cell line-derived neurotrophic factor for
midbrain dopaminergic neurons. Science 260, 1130–1132.
Mason, A. J., Hayflick, J. S., Ling, N., Esch, F., Ueno, N., Ying, S.-Y.,
Guillemin, R., Niall, H., and Seeburg, P. H. (1985). Complemen-
tary DNA sequences of ovarian follicular fluid inhibin show
precursor structure and homology with transforming growth
factor-b. Nature 318, 659–663.
Mayo, K. E., Cerelli, G. M., Spiess, J., Rivier, J., Rosenfeld, M. G.,
Evans, R. M., and Vale, W. (1986). Inhibin A-subunit cDNA’s
from porcine ovary and human placenta. Proc. Natl. Acad. Sci.
USA 83, 5849–5853.
McAlhany, R. J., West, J., and Miranda, R. (1997). Glial-derived
neurotrophic factor rescues calbindin-D28k-immunoreactive
neurons in alcohol-treated cerebellar explant cultures. J. Neuro-
biol. 33, 835–47.
McGrath, S. A., Esquela, A. F., and Lee, S.-J. (1995). Oocyte-specific
expression of growth/differentiation factor-9. Mol. Endocrinol. 9,
131–136.
McPherron, A. C., Lawler, A. M., and Lee, S.-J. (1997). Regulation of
skeletal muscle mass in mice by a new TGF-b superfamily
member. Nature 387, 83–90.
McPherron, A. C., and Lee, S.-J. (1993). GDF-3 and GDF-9: Two
new members of the transforming growth factor-b superfamily
containing a novel pattern of cysteines. J. Biol. Chem. 268,
3444–3449.
cPherron, A. C., and Lee, S.-J. (1996). The transforming growth
factor b superfamily. In “Growth Factors and Cytokines in
Health and Disease” (D. LeRoith and C. Bondy, Eds.), pp.
357–393. JAI Press, Greenwich, CT.
eno, C., Saijoh, Y., Fujii, H., Ikeda, M., Yokoyama, T., Yokoyama,
M., Toyoda, Y., and Hamada, H. (1996). Left–right asymmetric
expression of the TGF beta-family member lefty in mouse
embryos. Nature 381, 151–5.Meno, C., Shimono, A., Saijoh, Y., Yashiro, K., Mochida, K.,
Ohishi, S., Noji, S., Kondoh, H., and Hamada, H. (1998). lefty-1 is
s of reproduction in any form reserved.
79Characterization of GDF-10required for left–right determination as a regulator of lefty-2 and
nodal. Cell 94, 287–297.
Milbrandt, J., de Sauvage, F., Fahrner, T., Baloh, R., Leitner, M.,
Tansey, M., Lampe, P., Heuckeroth, R., Kotzbaue, P., Simburger,
K., Golden, J., Davies, J., Vejsada, R., Kato, A., Hynes, M.,
Sherman, D., Nishimura, M., Wang, L., Vandlen, R, Moffat, B.,
Klein, R., Poulsen, K., Gray, C., Garces, A., and Johnson, E. J.
(1998). Persephin, a novel neurotrophic factor related to GDNF
and neurturin. Neuron 2, 245–253.
Mittl, P. R., Priestle, J. P., Cox, D. A., McMaster, G., Cerletti, N.,
and Grutter, M. G. (1996). The crystal structure of TGF-b3 and
comparison to TGF-b2: Implications for receptor binding. Pro-
tein Sci. 5, 1261–1271.
Mount, H., Dean, D., Alberch, J., Dreyfus, C., and Black, I. (1995).
Glial cell line-derived neurotrophic factor promotes the survival
and morphologic differentiation of Purkinje cells. Proc. Natl.
Acad. Sci. USA 92, 9092–9096.
Sahin, M., and Hockfield, S. (1990). Molecular identification of the
Lugaro cell in the cat cerebellar cortex. J. Comp. Neurol. 301,
575–584.
Schachner, M., Hedley-Whyte, E. T., Hsu, D. W., Schoonmaker, G.,
and Bignami, A. (1977). Ultrastructural localization of glial
fibrillary acidic protein in mouse cerebellum by immunoperox-
idase labeling. J. Cell Biol. 75, 67–73.
Copyright © 1999 by Academic Press. All rightSchlunegger, M. P., and Grutter, M. G. (1992). An unusual feature
revealed by the crystal structure at 2.2 Å resolution of human
transforming growth factor-b2. Nature 358, 430–434.
Storm, E. E., Huynh, T. V., Copeland, N. G., Jenkins, N. A.,
Kingsley, D. M., and Lee, S.-J. (1994). Limb alterations in brachy-
podism mice due to mutations in a new member of the TGFb-
superfamily. Nature 368, 639–643.
Takahashi, H., and Ikeda, T. (1996). Transcripts for two members of
the transforming growth factor beta superfamily BMP-3 and BMP-7
are expressed in developing rat embryos. Dev. Dyn. 207, 439–449.
Wilkinson, D. G., Bailes, J. A., and McMahon, A. P. (1987).
Expression of the proto-oncogene int-1 is restricted to specific
cells in the developing mouse embryo. Cell 50, 79–88.
Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters,
M. J., Kriz, R. W., Hewick, R. M., and Wang, E. A. (1988). Novel
regulators of bone formation: Molecular clones and activities.
Science 242, 1528–1534.
Zhou, X., Sasaki, H., Lowe, L., Hogan, B. L. M., and Kuehn, M. R.
(1993). Nodal is a novel TGF-b-like gene expressed in the mouse
node during gastrulation. Nature 361, 543–547.
Received for publication February 26, 1999
Revised May 5, 1999
Accepted May 5, 1999
s of reproduction in any form reserved.
